risankizumab
abbvie
['keepsake 1', 'risan']
ab2126 #acr22 risankizumab on enthesitis/dactylitis
keepsake 1&amp;2 - rzb v pbo
1407 pts -baseline 63% enth, 28% dact, 20% both
wk 24: 14% decr. enthesitis, 17% decr dact, 13% decr both
mean time to resolution decreased
results maintained through wk 52 
Rheumatologist at Institute for Rheumatic and Autoimmune Disease at Overlook Hospital, proud Hopkins alum, health care advocate, Eagles fan entering Giants land